Share-Based Stock Options for Directors
First written in FY2017-Q1. 6 of 12 entries say "Restated". Latest entry: FY2025.
- FY2025RestatedAnnual report
「The number of stock options is determined with reference to monthly fixed compensation, taking into account that the plan was introduced as a replacement for directors' retirement bonuses, as the options constitute compensation linked to shareholder returns. They are granted once a year by resolution of the Board of Directors based on the recommendations of the Nomination and Compensation Advisory Committee. In the current fiscal year, no stock options were granted in view of the challenging business environment.」
The policy for the stock-based compensation stock option plan was maintained, but no grants were made in the current fiscal year because of the challenging business environment. - FY2022RestatedAnnual report
「No stock options were granted in the current fiscal year in view of the challenging business environment.」
The stock option plan was maintained, but no grants were made in the current fiscal year because of the challenging business environment. - FY2021SoftenedAnnual report
「The number of stock options is determined with reference to monthly fixed compensation, taking into account that the plan was introduced as a replacement for directors' retirement bonuses, as the options constitute compensation linked to shareholder returns. They are granted once a year by resolution of the Board of Directors based on the recommendations of the Nomination and Compensation Advisory Committee. In the current fiscal year, no stock options were granted in view of the challenging business environment.」
The stock-based compensation stock option plan itself was maintained, but no grants were made in the current fiscal year because of the challenging business environment. - FY2020-Q2AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 12 September 2019, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to its directors as stock-based compensation stock options. 1. Eligible recipients and number: 4 Company directors. 2. Number of stock acquisition rights to be allocated: 154. (3) Exercise period for the stock acquisition rights: from 1 October 2019 to 30 September 2049.」
Resolved to grant 154 stock acquisition rights to 4 directors as new stock-based compensation stock options, with an exercise period from 1 October 2019 to 30 September 2049. - FY2019-Q2RestatedAnnual report
「The stock acquisition rights issued during the second quarter are as follows.」
Disclosed the issuance terms for the stock acquisition rights resolved on 6 July 2018: 202 rights, representing 20,200 underlying shares, with an exercise period from 1 August 2018 to 31 July 2048. - FY2019-Q1AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 6 July 2018, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to its directors as stock-based compensation stock options.」
Resolved to make a new issuance of 202 stock acquisition rights to 5 directors, with an exercise period from 1 August 2018 to 31 July 2048. - FY2018RestatedAnnual report
「At a meeting of the Company's Board of Directors held on 7 July 2017, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to 5 directors as stock-based compensation stock options.」
The Company continues to disclose 201 stock-based compensation stock options for 5 directors, representing 20,100 underlying shares. - FY2018-Q2RestatedAnnual report
「The stock acquisition rights issued during the second quarter are as follows.」
The Company continues to disclose the issuance terms for 201 stock-based compensation stock options for directors, representing 20,100 underlying shares, with an exercise period from 1 August 2017 to 31 July 2047. - FY2018-Q1AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 7 July 2017, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to 5 directors as stock-based compensation stock options. Number of stock acquisition rights to be allocated: 201. From 1 August 2017 to 31 July 2047.」
Resolved to allocate 201 stock acquisition rights to 5 directors, with an exercise period from August 2017 to July 2047. - FY2017RestatedAnnual report
「At the annual general meeting held on 23 May 2012, the Company resolved to abolish the directors' retirement bonus plan and introduce a stock-based compensation stock option plan equivalent to the directors' retirement bonuses, in order to clarify directors' responsibility for management performance and establish a fair, highly transparent executive compensation system.」
The Company continues to offer stock-based compensation stock options for directors as part of its executive compensation system. - FY2017-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter are as follows.」
Disclosed the issuance terms for 225 stock-based compensation stock options for directors, representing 22,500 underlying shares, with an exercise period from 1 August 2016 to 31 July 2046. - FY2017-Q1First statedAnnual report
「At a meeting of the Board of Directors held on 8 July 2016, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights as stock options to 4 directors of the company. Number of stock acquisition rights to be allotted 225 From 1 August 2016 to 31 July 2046」
Resolved to allocate 225 stock acquisition rights to 4 directors under a stock-based compensation plan with a 30-year exercise period.